Why HTA Compass?
HTA Compass provides biopharma companies with timely, structured, and strategic solution to navigate JCA submissions, ensuring successful HTA outcomes.
Joint Clinical Assessments (JCAs) under the new EU HTA regulation require precision, efficiency, and seamless collaboration to meet strict timelines. HTA Compass maximizes efficiency by streamlining submissions, driving cross-functional collaboration, and centralizing workflows. Its robust dashboards transform data into actionable insights, enabling timely decision-making and ensuring submission readiness.
Adaptable across therapy areas and scalable for companies of all sizes, HTA Compass delivers tailored solutions to meet the unique needs of your business.
HTA Compass is more than a tool—it’s your trusted partner for regulatory compliance, operational excellence, and successful JCA dossier submissions, accelerating patient access.
Joint Clinical Assessments (JCAs) under the new EU HTA regulation require precision, efficiency, and seamless collaboration to meet strict timelines. HTA Compass maximizes efficiency by streamlining submissions, driving cross-functional collaboration, and centralizing workflows.
Its robust dashboards transform data into actionable insights, enabling timely decision-making and ensuring submission readiness.
Adaptable across therapy areas and scalable for companies of all sizes, HTA Compass delivers tailored solutions to meet the unique needs of your business.
HTA Compass is more than a tool—it’s your trusted partner for regulatory compliance, operational excellence, and successful JCA dossier submissions, accelerating patient access.
HTA Compass
What does it offer?
Achieve Strategic Alignment
and Compliance
Streamline Compliance with Deadlines: Ensure timely, structured submissions to meet the regulatory deadlines
Facilitate Cross-Functional Collaboration:
Unite cross-functional teams—market access, HEOR, regulatory,
clinical, medical, commercial, biostatistics, patient advocacy, policy,
and legal—for streamlined and impactful submission strategies
Enhance Operational Efficiency
Centralized Submission Management: A unified platform to manage, track, and optimize dossier submission planning
Optimize Workflow with Real-Time Updates: Monitor progress, track timelines, and manage responsibilities effortlessly
Enable Customization and Scalability
Adaptable for All Therapy Areas:
From oncology and rare diseases to multiple therapy areas, with tailored recommendations to meet therapy-specific needs.
Scalable for emerging biotechs, mid-sized enterprises, and large pharma: Designed to support companies at every stage of dossier submission maturity
Modular Features for Targeted Use: Choose between comprehensive solutions or specific functionalities tailored to your business needs
Support Data-Driven Decision Making
Access Robust Dashboards for Progress Monitoring:
Gain a holistic view of submission readiness across all cross-functional teams to inform strategic decisions
HTA Compass
Impact
Strategic Market Access
and Business Impact
Accelerate Market Entry Across the EU: Enable faster access to patients and quicker revenue realization.
Plan Submissions Strategically: Incorporate HTA evaluation needs and country-specific considerations to strengthen value demonstration.
Patient and Societal Value
Accelerate Access to Life-Saving Treatments: Expedite the timeline for patients to benefit from innovative therapies.
HTA Compass
What does it offer?
Achieve Strategic Alignment and Compliance
Streamline Compliance with Deadlines:
Ensure timely, structured submissions to meet the regulatory deadlines
Facilitate Cross-Functional Collaboration:
Unite cross-functional teams—market access, HEOR, regulatory, clinical, medical, commercial, biostatistics, patient advocacy, policy, and legal—for streamlined and impactful submission strategies
Enhance Operational Efficiency
Centralized Submission Management: A unified platform to manage, track, and optimize dossier submission planning
Optimize Workflow with Real-Time Updates: Monitor progress, track timelines, and manage responsibilities effortlessly
Enable Customization and Scalability
Adaptable for All Therapy Areas:
From oncology and rare diseases to multiple therapy areas, with tailored recommendations to meet therapy-specific needs.
Scalable for emerging biotechs, mid-sized enterprises, and large pharma: Designed to support companies at every stage of dossier submission maturity
Modular Features for Targeted Use: Choose between comprehensive solutions or specific functionalities tailored to your business needs
Support Data-Driven Decision Making
Access Robust Dashboards for Progress Monitoring:
Gain a holistic view of submission readiness across all cross-functional teams to inform strategic decisions
Facilitate Cross-Functional Collaboration:
Unite cross-functional teams—market access, HEOR, regulatory, clinical, medical, commercial, biostatistics, patient advocacy, policy, and legal—for streamlined and impactful submission strategies
HTA Compass
Impact
Strategic Market Access
and Business Impact
Accelerate Market Entry Across the EU: Enable faster access to patients and quicker revenue realization.
Plan Submissions Strategically: Incorporate HTA evaluation needs and country-specific considerations to strengthen value demonstration.
Patient and Societal Value
Accelerate Access to Life-Saving Treatments: Expedite the timeline for patients to benefit from innovative therapies.
HTA Compass
What does it offer?
Achieve Strategic Alignment
and Compliance
Streamline Compliance with Deadlines: Ensure timely, structured submissions to meet the regulatory deadlines
Facilitate Cross-Functional Collaboration: Unite cross-functional teams—market access, HEOR, regulatory,
clinical, medical, commercial, biostatistics, patient advocacy, policy,
and legal—for streamlined and impactful submission strategies
Enhance Operational Efficiency
Centralized Submission Management: A unified platform to manage, track, and optimize dossier submission planning
Optimize Workflow with Real-Time Updates: Monitor progress, track timelines, and manage responsibilities effortlessly
Enable Customization
and Scalability
Adaptable for All Therapy Areas:
From oncology and rare diseases to multiple therapy areas, with tailored recommendations to meet therapy-specific needs.
Scalable for emerging biotechs, mid-sized enterprises, and large pharma: Designed to support companies at every stage of dossier submission maturity
Modular Features for Targeted Use: Choose between comprehensive solutions or specific functionalities tailored to your business needs
Support Data-Driven
Decision Making
Access Robust Dashboards for Progress Monitoring:
Gain a holistic view of submission readiness across all cross-functional teams to inform strategic decisions
HTA Compass
Impact
Strategic Market Access
and Business Impact
Strategic Market
Access and
Business Impact
Streamline Compliance with Deadlines: Ensure timely, structured submissions to meet the regulatory deadlines
Facilitate Cross-Functional Collaboration: Unite cross-functional teams—market access, HEOR, regulatory,
clinical, medical, commercial, biostatistics, patient advocacy, policy,
and legal—for streamlined and impactful submission strategies
Patient and
Societal Value
Accelerate Access to Life-Saving Treatments: Expedite the timeline for patients to benefit from innovative therapies.
Book a Demo Below
Book a Demo Below
Strategic Pathways
for Better Patient Lives
Let’s achieve your goals together
Tak Biosuisse 2025
Strategic Pathways
for Better Patient Lives
Let’s achieve your goals together
Tak Biosuisse 2025
Strategic Pathways
for Better Patient Lives
Let’s achieve your goals together
Tak Biosuisse 2025